Evidence map›Paper›PMID 32046317›Full record

ReviewInternational journal of molecular sciences2020

Using Probiotics as Supplementation for

Jianfu Ji, Hong Yang

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 2 pooled it
19.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 2 syntheses or guidelines pooled it, 151 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Evaluation of efficacy and safety ofFrontiers in immunology · 2024
    Trial
  4. Review
  5. Review
  6. Integrative profiling ofMicrobial genomics · 2026
    Article
  7. Novel non-antibiotic triple therapy forFrontiers in medicine · 2026
    Article
  8. Article
  9. Genomic characterization and biological activities of cell-free supernatant fromFrontiers in cellular and infection microbiology · 2026
    Article
  10. Current concepts of Helicobacter pylori infection.European journal of medical research · 2025
    Review
  11. Review
  12. Article
  13. Towards EffectiveInternational journal of molecular sciences · 2025
    Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Diseases (Basel, Switzerland) · 2024
    Review
  19. Review
  20. Review

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jianfu JiState Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 201100, China.
Hong YangState Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 201100, China.
Shanghai Jiao Tong University · CN

Funding

Shanghai Industry-University Joint Research Program HUCXY-2016-010
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gastrointestinal MicrobiomeHelicobacter pyloriAnimalsAnti-Bacterial AgentsCombined Modality TherapyHelicobacter InfectionsHumansProbioticsAnti-Bacterial Agentsantibiotic therapyHelicobacter pyloriprobiotic therapy

Identifiers

PMID32046317
PMCPMC7037652
OpenAlexW3004838847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.